Home | About | Products | Collaborative Partners | Investors | Newsroom | Careers | Contact Us | Site Map
© 2011 Kythera Biopharmaceuticals, Inc. | Website by RBD
KYTHERA’s lead clinical program, ATX-101, is focused on the reduction of submental (‘under the chin’) fat. The company also has active research programs with focused interest in hair and fat biology, pigmentation modulation and facial contouring.
KYTHERA’s product discovery process is driven by:
KYTHERA applies a rigorous, no-compromise approach to pre-clinical, clinical, manufacturing and quality for all programs that progress from the early research stage.
